AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19536077 — intervention group
Group type: COMPARATOR
Intervention: Control group (traditional cooking methods)
Number of subjects: 1047
Study 18549938 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifen
Number of subjects: 100
Study 18549938 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 16179086 — intervention group
Group type: EXPERIMENTAL
Intervention: Laminin chains in allergic asthmatics
Number of subjects: 27
Study 16179086 — intervention group
Group type: EXPERIMENTAL
Intervention: Laminin chains in non-allergic asthmatics
Number of subjects: 27
Study 16179086 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 27
Study 12385443 — intervention group
Group type: EXPERIMENTAL
Intervention: 125 mg SP-303
Number of subjects: 184
Study 12385443 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg SP-303
Number of subjects: 184
Study 12385443 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg SP-303
Number of subjects: 184
Study 12385443 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 184
Study 10102461 — intervention group
Group type: EXPERIMENTAL
Intervention: APTT screening in patients on OAT
Number of subjects: 734
Study 8703649 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (0.1 mu kg‐1 min‐1) during hypoxaemia (SpO2 80%)
Number of subjects: 12
Study 8703649 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental hypoxaemia (SpO2 90, 85, 80%)
Number of subjects: 12
Study 8703649 — intervention group
Group type: COMPARATOR
Intervention: Control arm (no propranolol) during hypoxaemia
Number of subjects: 12
Study 2185701 — intervention group
Group type: EXPERIMENTAL
Intervention: Turbuhaler inhaler at inhalation rates slower than 28 1/minute
Number of subjects: 72
Study 2185701 — intervention group
Group type: COMPARATOR
Intervention: Turbuhaler inhaler
Number of subjects: 72
Study 87092 — intervention group
Group type: EXPERIMENTAL
Intervention: FPL 57787 6 mg four times a day
Number of subjects: 14
Study 87092 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 31646806 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel + Cisplatin (DTX+DDP)
Number of subjects: 90
Study 31646806 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel + Cisplatin (TAX+DDP)
Number of subjects: 90
Study 29997169 — intervention group
Group type: EXPERIMENTAL
Intervention: PACT (Plans for Action and Care Transitions) intervention
Number of subjects: 147
Study 29997169 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 147
Study 26702601 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindful attention induction
Number of subjects: 40
Study 26702601 — intervention group
Group type: COMPARATOR
Intervention: Standard food-cue exposure
Number of subjects: 40
Study 24573385 — intervention group
Group type: EXPERIMENTAL
Intervention: FLT3 mutation
Number of subjects: 1312
Study 24573385 — intervention group
Group type: EXPERIMENTAL
Intervention: NPM1c mutation
Number of subjects: 1312
Study 24573385 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-parameter prognostic risk score with molecular information
Number of subjects: 1312
Study 22914405 — intervention group
Group type: EXPERIMENTAL
Intervention: 16‐French resectoscope
Number of subjects: 401
Study 22914405 — intervention group
Group type: COMPARATOR
Intervention: 22‐French resectoscope
Number of subjects: 401
Study 22914405 — intervention group
Group type: COMPARATOR
Intervention: 15‐French hysteroscope
Number of subjects: 401
Study 20582906 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 mg Ginkgo extract (EGb 761)
Number of subjects: 3069
Study 20582906 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3069
Study 18026906 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly gemcitabine (125 mg/m(2)) with cisplatin (40 mg/m(2)) and pelvic radiotherapy
Number of subjects: 7
Study 18026906 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin dosage reduction to 20 mg/m(2)
Number of subjects: 7
Study 16121513 — intervention group
Group type: EXPERIMENTAL
Intervention: KanJang oral solution (fixed combination of Echinacea purpurea, Adhatoda vasica, and Eleutherococcus senticosus)
Number of subjects: 0
Study 16121513 — intervention group
Group type: COMPARATOR
Intervention: Echinacea mixture (Echinacea purpurea and Eleutherococcus senticosus)
Number of subjects: 0
Study 16121513 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (Bromhexine)
Number of subjects: 0
Study 12586521 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived voluntary contraction efforts at levels 1-9 on an 11-point scale (0-10)
Number of subjects: 30
Study 12586521 — intervention group
Group type: EXPERIMENTAL
Intervention: Vastus medialis (VM) EMG
Number of subjects: 30
Study 12586521 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak torque (PT)
Number of subjects: 30
Study 12586521 — intervention group
Group type: EXPERIMENTAL
Intervention: Average torque (AT)
Number of subjects: 30
Study 12586521 — intervention group
Group type: EXPERIMENTAL
Intervention: Torque coefficient of variation (C.V.)
Number of subjects: 30
Study 10609984 — intervention group
Group type: EXPERIMENTAL
Intervention: d-amphetamine (indirect dopamine agonist)
Number of subjects: 0
Study 8953999 — intervention group
Group type: EXPERIMENTAL
Intervention: ED vaccination group (n = 611)
Number of subjects: 1835
Study 8953999 — intervention group
Group type: EXPERIMENTAL
Intervention: Letter group (n = 610)
Number of subjects: 1835
Study 8953999 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 614)
Number of subjects: 1835
Study 8953999 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 1835
Study 2002251 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital intradermal injections of histamine
Number of subjects: 0
Study 2002251 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital intradermal injections of substance P
Number of subjects: 0
Study 2002251 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital intradermal injections of calcitonin gene‐related peptide
Number of subjects: 0
Study 2002251 — intervention group
Group type: COMPARATOR
Intervention: Digital intradermal injections of saline
Number of subjects: 0
Study 2002251 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital intradermal injections of compound 48/80
Number of subjects: 0
Study 6760678 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (100-300 mg/day)
Number of subjects: 0
Study 6760678 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol (5-15 mg/day)
Number of subjects: 0
Study 30665440 — intervention group
Group type: EXPERIMENTAL
Intervention: First line ART
Number of subjects: 30
Study 30665440 — intervention group
Group type: EXPERIMENTAL
Intervention: Second line ART
Number of subjects: 30
Study 30665440 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous ART adherence education
Number of subjects: 30
Study 26684670 — intervention group
Group type: EXPERIMENTAL
Intervention: MOTR treatment
Number of subjects: 40
Study 26684670 — intervention group
Group type: COMPARATOR
Intervention: Comparison treatment
Number of subjects: 40
Study 25885650 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram (10-20 mg daily for 24 weeks)
Number of subjects: 29
Study 25885650 — intervention group
Group type: COMPARATOR
Intervention: Placebo (daily for 24 weeks)
Number of subjects: 29
Study 25885650 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram and Placebo (both groups)
Number of subjects: 29
Study 24335363 — intervention group
Group type: EXPERIMENTAL
Intervention: UFT/PSK
Number of subjects: 205
Study 24335363 — intervention group
Group type: COMPARATOR
Intervention: UFT
Number of subjects: 205
Study 20632194 — intervention group
Group type: EXPERIMENTAL
Intervention: Transjugular intrahepatic portosystemic shunt (TIPS)
Number of subjects: 60
Study 20632194 — intervention group
Group type: COMPARATOR
Intervention: Large-volume paracentesis plus albumin
Number of subjects: 60
Study 19567211 — intervention group
Group type: EXPERIMENTAL
Intervention: Bortezomib
Number of subjects: 0
Study 19567211 — intervention group
Group type: COMPARATOR
Intervention: High-dose dexamethasone (HDD)
Number of subjects: 0
Study 17901034 — intervention group
Group type: EXPERIMENTAL
Intervention: Nepafenac 0.1%
Number of subjects: 40
Study 17901034 — intervention group
Group type: COMPARATOR
Intervention: Ketorolac 0.4%
Number of subjects: 40
Study 15131767 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat group - standard meal plus a fat supplement of 300 kcal from different types of fat (butter, sunflower margarine, olive oil)
Number of subjects: 39
Study 15131767 — intervention group
Group type: COMPARATOR
Intervention: CHO group - standard meal plus a supplement of 300 kcal from different types of CHO (bread, coke, fruit)
Number of subjects: 39
Study 10797515 — intervention group
Group type: EXPERIMENTAL
Intervention: Acoustic rhinometry measurements
Number of subjects: 20
Study 9007706 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone followed by lymphoblastoid interferon
Number of subjects: 213
Study 9007706 — intervention group
Group type: COMPARATOR
Intervention: Placebo followed by lymphoblastoid interferon
Number of subjects: 213
Study 1649018 — intervention group
Group type: EXPERIMENTAL
Intervention: 99mTc(v) DMSA planar scintigraphy
Number of subjects: 26
Study 1649018 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical examination
Number of subjects: 26
Study 1649018 — intervention group
Group type: EXPERIMENTAL
Intervention: CT (computerized tomography)
Number of subjects: 26
Study 1649018 — intervention group
Group type: EXPERIMENTAL
Intervention: 99mTc(v) DMSA scintigraphy
Number of subjects: 26
Study 1649018 — intervention group
Group type: EXPERIMENTAL
Intervention: CT
Number of subjects: 26
Study 6832119 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75 ppm SO2 during heavy exercise with mouthpiece breathing
Number of subjects: 23
Study 6832119 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75 ppm SO2 during heavy exercise with unencumbered breathing
Number of subjects: 23
Study 6832119 — intervention group
Group type: COMPARATOR
Intervention: Clean air exposures
Number of subjects: 23
Study 6832119 — intervention group
Group type: EXPERIMENTAL
Intervention: Mouthpiece breathing
Number of subjects: 23
Study 6832119 — intervention group
Group type: EXPERIMENTAL
Intervention: Unencumbered breathing
Number of subjects: 23
Study 6832119 — intervention group
Group type: EXPERIMENTAL
Intervention: Mouthpiece breathing with SO2
Number of subjects: 23
Study 6832119 — intervention group
Group type: EXPERIMENTAL
Intervention: Unencumbered breathing with SO2
Number of subjects: 23
Study 30917899 — intervention group
Group type: EXPERIMENTAL
Intervention: VTE-BLEED score ≥2 points
Number of subjects: 522
Study 30917899 — intervention group
Group type: EXPERIMENTAL
Intervention: GFR <30 ml/min/1.73 m2
Number of subjects: 522
Study 30917899 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous surgery
Number of subjects: 522
Study 30917899 — intervention group
Group type: EXPERIMENTAL
Intervention: Unfractionated heparin as initial treatment
Number of subjects: 522
Study 30917899 — intervention group
Group type: EXPERIMENTAL
Intervention: Major bleeding
Number of subjects: 522
Study 30047376 — intervention group
Group type: EXPERIMENTAL
Intervention: Mosaic Ad26/Ad26 plus high-dose gp140 boost vaccine
Number of subjects: 393
Study 30047376 — intervention group
Group type: EXPERIMENTAL
Intervention: Mosaic Ad26/Ad26 plus low-dose gp140 boost vaccine
Number of subjects: 393
Study 30047376 — intervention group
Group type: COMPARATOR
Intervention: Control group (0.9% saline)
Number of subjects: 393
Study 30047376 — intervention group
Group type: EXPERIMENTAL
Intervention: Mosaic Ad26/Ad26 plus gp140 boost vaccine in rhesus monkeys
Number of subjects: 393
Study 25901480 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine + opioid
Number of subjects: 68
Study 25901480 — intervention group
Group type: COMPARATOR
Intervention: Placebo + opioid
Number of subjects: 68
Study 22288979 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month posttreatment window (first 90 days after the intervention)
Number of subjects: 467
Study 22288979 — intervention group
Group type: EXPERIMENTAL
Intervention: 90 days from the end of treatment
Number of subjects: 467
Study 22288979 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month TLFB follow-up time frame
Number of subjects: 467
Study 20663130 — intervention group
Group type: EXPERIMENTAL
Intervention: Tigecycline
Number of subjects: 199
Study 20663130 — intervention group
Group type: COMPARATOR
Intervention: Imipenem/cilastatin
Number of subjects: 199
Study 18367653 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusion of ANG II (5.0 ng.kg(‐1).min(‐1)) in PA
Number of subjects: 25
Study 18367653 — intervention group
Group type: COMPARATOR
Intervention: Infusion of ANG II (5.0 ng.kg(‐1).min(‐1)) in NC
Number of subjects: 25
Study 18367653 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous infusion of nitroprusside and ANG II in PA
Number of subjects: 25
Study 18367653 — intervention group
Group type: COMPARATOR
Intervention: Simultaneous infusion of nitroprusside and ANG II in NC
Number of subjects: 25
Study 18367653 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral adrenalectomy in PA
Number of subjects: 25
Study 15776134 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine (AZA) started at 1 mg/kg/day, titrated to 2.5 mg/kg/day after TPMT assay not performed (group 1)
Number of subjects: 29
Study 15776134 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine (AZA) started at 2.5 mg/kg/day after TPMT assay performed (group 2)
Number of subjects: 29
Study 12457784 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin (40 mg per day)
Number of subjects: 5804
Study 12457784 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5804
Study 10590386 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiocassette recording of consultation
Number of subjects: 60
Study 10590386 — intervention group
Group type: COMPARATOR
Intervention: No audiocassette recording
Number of subjects: 60
Study 8869807 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Number of subjects: 0
Study 8869807 — intervention group
Group type: EXPERIMENTAL
Intervention: Irinotecan
Number of subjects: 0
Study 8869807 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel
Number of subjects: 0
Study 8869807 — intervention group
Group type: EXPERIMENTAL
Intervention: Tomudex
Number of subjects: 0
Study 1861939 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention (three brief videotapes and written materials)
Number of subjects: 141
Study 1861939 — intervention group
Group type: COMPARATOR
Intervention: Control (health education videotapes and comparable materials)
Number of subjects: 141
Study 6485418 — intervention group
Group type: EXPERIMENTAL
Intervention: Orotic acid in combination with clofibrinic acid
Number of subjects: 0
Study 6485418 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 30832598 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention (Group 1)
Number of subjects: 133
Study 30832598 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention plus port protector (Group 2)
Number of subjects: 133
Study 30832598 — intervention group
Group type: COMPARATOR
Intervention: Observational period (Control)
Number of subjects: 133
Study 30286798 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention of leadership training and problem-solving during daily huddles
Number of subjects: 0
Study 30286798 — intervention group
Group type: COMPARATOR
Intervention: Standard care (huddles without support or training)
Number of subjects: 0
Study 27253770 — intervention group
Group type: EXPERIMENTAL
Intervention: Blue light (469 nm)
Number of subjects: 35
Study 27253770 — intervention group
Group type: COMPARATOR
Intervention: Amber light (578 nm)
Number of subjects: 35
Study 24946001 — intervention group
Group type: EXPERIMENTAL
Intervention: Androgen deprivation therapy (ADT)
Number of subjects: 39
Study 24946001 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy (SPC)
Number of subjects: 39
Study 22753019 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine 0.6 mg single dose in young subjects
Number of subjects: 38
Study 22753019 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine 0.6 mg single dose in elderly subjects
Number of subjects: 38
Study 22753019 — intervention group
Group type: COMPARATOR
Intervention: Comparison of pharmacokinetic parameters between young and elderly subjects
Number of subjects: 38
Study 20131255 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose colchicine (1.8 mg total over 1 hour)
Number of subjects: 184
Study 20131255 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose colchicine (4.8 mg total over 6 hours)
Number of subjects: 184
Study 20131255 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 184
Study 20131255 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose colchicine
Number of subjects: 184
Study 20131255 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose colchicine
Number of subjects: 184
Study 17175393 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental control
Number of subjects: 98
Study 17175393 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental warmth
Number of subjects: 98
Study 17175393 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental limit setting and autonomy support
Number of subjects: 98
Study 17175393 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurturance and involvement
Number of subjects: 98
Study 18082856 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal contraceptive ring
Number of subjects: 130
Study 18082856 — intervention group
Group type: COMPARATOR
Intervention: Oral contraceptive pills
Number of subjects: 130
Study 15095939 — intervention group
Group type: EXPERIMENTAL
Intervention: External reference cues added when body-centered coding was disrupted
Number of subjects: 0
Study 15095939 — intervention group
Group type: EXPERIMENTAL
Intervention: External reference cues added to intact body-centered reference
Number of subjects: 0
Study 15095939 — intervention group
Group type: COMPARATOR
Intervention: Body-centered reference disrupted by orienting the map differently
Number of subjects: 0
Study 10965832 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic repair
Number of subjects: 18
Study 10965832 — intervention group
Group type: COMPARATOR
Intervention: Open tension‐free repair
Number of subjects: 18
Study 9068513 — intervention group
Group type: EXPERIMENTAL
Intervention: Acebutolol
Number of subjects: 607
Study 9068513 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 607
Study 8249222 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin for 2 weeks
Number of subjects: 143
Study 8249222 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline for 2 weeks
Number of subjects: 143
Study 8249222 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 143
Study 2412262 — intervention group
Group type: EXPERIMENTAL
Intervention: Leucocyte interferon in daily doses of 3 x 10(6) I.U.i.m
Number of subjects: 20
Study 2412262 — intervention group
Group type: COMPARATOR
Intervention: Irradiation of both lungs in a calculated mean central dose of 10 Gy in 4 weeks in combination with bleomycin and vincristine
Number of subjects: 20
Study 11172448 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition intervention tailored to patient-specific barriers (52 patients)
Number of subjects: 83
Study 11172448 — intervention group
Group type: COMPARATOR
Intervention: Usual care (31 patients)
Number of subjects: 83
Study 31283605 — intervention group
Group type: EXPERIMENTAL
Intervention: 18F-fluciclovine
Number of subjects: 58
Study 31283605 — intervention group
Group type: COMPARATOR
Intervention: 68Ga-PSMA-11
Number of subjects: 58
Study 29554789 — intervention group
Group type: EXPERIMENTAL
Intervention: Instructional video on performance of vascular anastomosis using visualization
Number of subjects: 32
Study 29554789 — intervention group
Group type: COMPARATOR
Intervention: Expert-guided simulator training alone
Number of subjects: 32
Study 29554789 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 32
Study 26833358 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination antiretroviral treatment (cART) started at a mean age of 8.1 months
Number of subjects: 68
Study 26833358 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination antiretroviral treatment (cART)
Number of subjects: 68
Study 24434783 — intervention group
Group type: EXPERIMENTAL
Intervention: Child intervention with massage and humor therapy
Number of subjects: 171
Study 24434783 — intervention group
Group type: EXPERIMENTAL
Intervention: Child intervention with massage and relaxation/imagery
Number of subjects: 171
Study 24434783 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 171
Study 24434783 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 171
Study 22845045 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-compound ointment (calcipotriol 50 μg/g; betamethasone dipropionate 0.5 mg/g)
Number of subjects: 24
Study 22845045 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-compound gel (calcipotriol 50 μg/g; betamethasone dipropionate 0.5 mg/g)
Number of subjects: 24
Study 22845045 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriol ointment (50 μg/g)
Number of subjects: 24
Study 22845045 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriol/hydrocortisone ointment (calcipotriol 25 μg/g; hydrocortisone 10 mg/g)
Number of subjects: 24
Study 22845045 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriol cream (50 μg/g)
Number of subjects: 24
Study 22845045 — intervention group
Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 24
Study 20803154 — intervention group
Group type: EXPERIMENTAL
Intervention: Fighting simulation (3 fights, 6 min each, 30 min rest between fights)
Number of subjects: 20
Study 17608155 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific immunotherapy
Number of subjects: 30
Study 17608155 — intervention group
Group type: COMPARATOR
Intervention: Medication only (antihistamines and intranasal corticosteroids)
Number of subjects: 30
Study 15652441 — intervention group
Group type: EXPERIMENTAL
Intervention: OAD morphine (mean 238 +/- 319 mg q24h)
Number of subjects: 25
Study 15652441 — intervention group
Group type: COMPARATOR
Intervention: twice-daily CR morphine (mean 119 +/- 159 mg q12h)
Number of subjects: 25
Study 15652441 — intervention group
Group type: EXPERIMENTAL
Intervention: OAD morphine
Number of subjects: 25